Little is known about the effect of inhalation of methanol and other solvents on the pregnancy and the growth of the fetus. We report a preterm male infant who developed cerebral infarcts in utero, leading to large areas of bilateral frontal cortical leukomalacia following chronic maternal inhalation of carburetor-cleaning fluid during pregnancy. The infant presented with acute fetal distress with significant metabolic acidosis at birth. Initial hypotonia was followed by generalized hypertonicity. This infant did not exhibit typical facial features of fetal alcohol syndrome.
INTRODUCTION
Solvent abuse continues to be widespread among adolescents and young adults. The solvents are cheap, easily available, and can be legally purchased by minors. Solvents usually do not have a strong alcohol odor and may not be detectable on the breath of the abuser. The abuse is likely to be seen in poor socio-economic areas and among kids from broken homes. The National Institute on Drug Abuse indicates that 12,000 pregnant women abuse inhalants each year. 1 NHSDA data show that, between 2000 and 2001, the number of people aged 12 years and older having used inhalants at least once in their lifetime rose by roughly 1.5 million, to over 18 million users. The highest past year use was among 14-and 15-year olds, with 4.2% inhalants use in the year preceding the survey and 1.3% for the month preceding the survey. 2 The inhaled solvent finds easy access into circulation through the large capillary surface area of the lungs. This leads to rapid absorption of solvents. The solvent abuse gives a short-lived rapid rush. The solvent may be inhaled by ''sniffing'' directly from the container, ''huffed'' from a rag soaked in the chemical or by ''bagging''. The experienced user may prolong the effect of exposure by sniffing through a plastic bag. Sudden death may result from asphyxia, vagal inhibition, respiratory depression, or arrhythmia. Polydrug abuse is not common among solvent abusers.
CASE REPORT
A 1699 g, 31-week gestation, appropriate for gestational age, premature, white male infant was born by emergency Cesarean section with Apgar sores of 5 at one and 7 at 5 minutes, respectively, to a 21-year-old, G2P0101, white mother. She has had previous Cesarean section for abruption of placenta at 33 weeks of gestation. She had past history of gonorrhea and Trichomonas vaginalis infection. She admitted to carburetor cleaner fluid inhalation repeatedly during this pregnancy. She was brought to the emergency room on several occasions during this pregnancy in acute intoxication. She denied history of any ethanol ingestion, i.v. drug abuse or other substance abuse. She was admitted to the hospital at 16 weeks of gestation in severe anion gap hyperosmolar metabolic acidosis. She had a blood methanol level of 48 mg/dl. Her blood ethylene glycol level was negative. She required aggressive management of acidosis, i.v. ethanol drip for about 27 hours, and i.v. folic acid. She was readmitted at 27 weeks of gestation with acute intoxication in severe hyperosmolar acidosis (serum osmolality of 309 and anion gap of 30) with low urine output. She had a blood methanol level of 43 mg/dl. She was treated with i.v. sodium bicarbonate, hemodialysis, and i.v. ethanol drip. She was found obtunded at 31 weeks of gestation. She was given (i.v.) sodium bicarbonate to correct acidosis and i.v. ethanol. This was followed by an emergency Cesarean section for acute fetal distress.
The infant was resuscitated with stimulation and suction, blow by O 2 and brief bag valve mask ventilation. The infant had respiratory distress soon after delivery. Chest X-ray was consistent with hyaline membrane disease. The initial blood gas indicated a pH 7.15, pCO 2 82 and base excess of À16. Meconium methanol level was 16 mg/dl. Meconium and urine were negative for cannabinoids or opiates. The infant had metabolic acidosis lasting for approximately 10 hours. He required surfactant administration, ventilatory support for about 24 hours and supplemental oxygen support for 1 week. Several episodes of apnea were noted during the hospital stay. The infant did not exhibit clinical features of fetal alcohol syndrome and he did not have typical features of drugwithdrawal syndrome. He had initial hypotonia followed by hypertonicity of lower extremities within a week after birth. Neurosonogram (Figure 1) showed bifrontal cystic lesions in the frontal area. The frontal cysts measured 1 cm Â 1 cm on the right side and 8 cm Â 9 cm on the left side. Magnetic resonant imaging done on day 3 (Figures 2, 3) showed extensive bifrontal cystic leukomalacia with some cortical atrophy and the areas of leukomalacia not communicating with the ventricles. Ventricular size was normal. There was no midline shift. The infant passed initial hearing screen from both ears.
DISCUSSION

Aerosol carburetor cleaner
3 contains 45% to 50% toluene, 20% to 25% acetone, and 20% to 25% methanol. The solvents are highly volatile and are readily absorbed by the skin and lungs. Methanol is found in a variety of commercial products like automotive windshield washer fluids and de-icers, carburetor-cleaning fluids, paints, shellacs, varnishes, wood stains, paint thinners and removers, and gasoline additives. Methanol is metabolized by alcohol dehydrogenase and is converted to formic acid, leading to metabolic acidosis and increased anion gap. 4 Formic acid is responsible for the major toxicity associated with methanol poisoning; folic acid is required for the conversion of formate to carbon dioxide and water. Methanol toxicity is enhanced with folate deficiency. Formic acid produces an anion gap metabolic acidosis. Methanol poisoning should be considered strongly with a presentation of an unexplained anion gap metabolic acidosis and/ or unexplained sudden visual impairment.
Early symptoms of acute methanol intoxication are loss of consciousness, headache, and dizziness. Abdominal pain can be due to acute gastritis or pancreatitis. The toxicity can lead to transient or permanent visual loss. In adults, cerebral edema may be seen in severely ill patients. Frontal lobe and basal ganglia hemorrhages and infarcts, especially of the putamen, have been 
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Fetal Cerebral Infarcts with Maternal Solvent Abuse reported in patients with methanol poisoning. 5 Scheeres, 6 in a recently published Canadian study of 56 pregnancies with methanol abuse, reported 21% incidence of preterm birth, 16% major anomalies, 12.5% fetal alcohol syndrome, and 11% hearing loss. Acute methanol poisoning is treated 7 with intravenous ethanol or formepizole and or dialysis. Pending serum methanol levels, it is recommended to institute ethanol or formepizole therapy. Serum formate is an important diagnostic tool for diagnosis of methanol toxicity with a severe, unexplained anion gap metabolic acidosis. Associated elevation of serum amylase and lipase suggests methanol-induced pancreatitis. Syrup of ipecac is avoided because of the risk of aspiration. Gastric lavage may be helpful if methanol has been ingested within 30 to 60 minutes of presentation.
Ethanol has 20 times increased affinity for alcohol dehydrogenase than methanol. Ethanol is given as a 10% solution in 5% dextrose 10 ml/kg bolus over 30 minutes, and serum level is kept at 100 to 150 mg/dl. The maintenance dose is doubled with concomitant dialysis. The patient should be monitored for hypoglycemia and CNS depression. Formepizole 8, 9 has over 8000 times affinity for alcohol dehydrogenase and it is not associated with hypoglycemia. Formepizole is given in an initial dose of 15 mg/kg i.v. over 30 minutes, 10 mg/kg q 12 hours for four doses, and then 15 mg/kg q 12 hours until the serum methanol level is less than 20 mg/dl. The dose is increased with dialysis.
Hemodialysis is very useful for removing methanol and its toxic metabolic byproducts. Dialysis is indicated with suspected methanol ingestion with visual symptoms, severe CNS dysfunction, large anion gap metabolic acidosis regardless of the serum methanol level, worsening acidosis despite ethanol therapy, and serum methanol level of over 50 mg/dl. It is repeated until the serum methanol is less than 20 mg/dl or until the patient is asymptomatic and the metabolic acidosis has resolved. The patient should also be given 50 mg folic acid every 4 hours to metabolize formic acid to CO 2 and H 2 O. Toluene 9,10 is another important toxic ingredient of solvents. The fetus or newborn does not make the conversion of toluene to hippuric acid. Significant number of miscarriages is reported with occupational exposure to toluene.
11,12 Syrovadko 13 reported higher incidence of fetal asphyxia and low birth weight in workers exposed to varnishes containing toluene at a level of 55 ppm. Toluene toxicity can be associated with dysmorphic facial features, identical to fetal alcohol syndrome. Organic solvent exposure in pregnancy is reported to be a risk factor for ventricular septal defect.
14 There is increased risk for preterm birth, low birth weight, microcephaly, growth retardation, development delay, abnormal palmar creases, blunt fingertips, small fingernails, deep-set eyes, micrognathia, and abnormal ears.
Metabolic acidosis and other metabolites of methanol may interfere with the normal neurotransmission and neuronal growth. Lower striatal dopamine levels were found in methanol-exposed rats with aberrant increase in the expression of growth-associated protein (GAP-43), a neuron-specific growth-associated protein in the hippocampal region as compared to their respective controls. 15 Formate inhibits the cytochrome oxidase complex at cytochrome aa 3 . 16 This inhibition decreases ATP production, 17 disrupting cellular homeostasis and increasing anaerobic glycolysis and lactate production. Formate and lactate accumulation crosses cellular membranes to produce further toxicity with altered intracellular calcium. Free radicals associated with acidosis and the effect of other metabolites of methanol induces lipid peroxidation, causing injury to the cellular membranes and mitochondria. The results of these pathophysiologic effects are cellular damage, specifically in rapidly developing brain in the first trimester. Neuropathological changes in the form of shrinkages and degeneration of neurons, primarily in the parietal cortex, have been reported. 18 Maternal methanol toxicity is associated with rapid fetoplacental vasoconstriction in response to maternal hypoxia. Exposure of methanol in the first trimester affects organogenesis and leads to craniofacial abnormalities.
Cephalic neural tube defects are reported in near-term mouse fetuses following maternal inhalation of methanol at high concentration during neurulation. 19 Dysraphism was seen in 15% of the fetuses. Significant neural pathology may remain in older conceptuses even in the absence of gross lesions. Esophageal stenosis and omphalocele or gastroschisis have been reported in the infants of women exposed to solvents. 20, 21 Cleft lip and cleft palate, sacral agenesis, gastrointestinal abnormalities, and ventricular septal defects are more prevalent with solvent exposure in pregnancy. [22] [23] [24] [25] [26] Drug-withdrawal syndrome, 27 identical to opiate withdrawal, has been reported with solvent abuse. Hyperactive Moro reflex, hypotonia, and high pitched cry are the typical clinical features. Finnegan scoring may be helpful to monitor the degree and the duration of withdrawal syndrome. Some patients may require phenobarbital therapy. The characteristic chemical odor in the newborn infant or mother is a marker for the diagnosis. An early intervention and a long term multidisciplinary follow-up are indicated because of a risk for the developmental delay, visual deficit, deafness, and cerebral palsy.
